Related Experiment Video
Updated: Dec 22, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Incidence of venous thromboembolism in hospitalized patients with COVID-19
Saskia Middeldorp1, Michiel Coppens1, Thijs F van Haaps1
1Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Insights
Hospitalized patients with COVID-19 have a high risk of venous thromboembolism (VTE), especially those in the intensive care unit (ICU). This highlights the need for increased clinical suspicion and diagnostic imaging for VTE in these patients.
Area of Science:
- Medicine
- Pulmonology
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) is associated with systemic coagulation activation.
- Thrombotic complications are a significant concern in COVID-19 patients.
Purpose of the Study:
- To determine the incidence of objectively confirmed venous thromboembolism (VTE) in hospitalized COVID-19 patients.
- To assess the risk of VTE in relation to intensive care unit (ICU) admission and patient outcomes.
Main Methods:
- A single-center cohort study was conducted with 198 hospitalized COVID-19 patients.
- Data were collected during a median follow-up of 7 days.
- VTE diagnosis was objectively confirmed, and symptomatic VTE was specifically noted.
Main Results:
- 20% of patients were diagnosed with VTE, and 13% had symptomatic VTE, despite routine prophylaxis.
- The cumulative incidence of VTE at 21 days was 42%, and symptomatic VTE was 25%.
- VTE was associated with an increased risk of death (adjusted HR, 2.4), with higher incidences observed in ICU patients compared to those on general wards.
Conclusions:
- The risk of VTE in hospitalized COVID-19 patients is high, particularly in the ICU.
- A high level of clinical suspicion and a low threshold for diagnostic imaging (for deep vein thrombosis [DVT] or pulmonary embolism [PE]) are recommended.
- Future research should focus on optimizing VTE diagnostic and prophylactic strategies to improve survival in COVID-19 patients.
Background:
Coronavirus disease 2019 (COVID-19) can lead to systemic coagulation activation and thrombotic complications.
Objectives:
To investigate the incidence of objectively confirmed venous thromboembolism (VTE) in hospitalized patients with COVID-19.
Methods:
Single-center cohort study of 198 hospitalized patients with COVID-19.
Results:
Seventy-five patients (38%) were admitted to the intensive care unit (ICU). At time of data collection, 16 (8%) were still hospitalized and 19% had died. During a median follow-up of 7 days (IQR, 3-13), 39 patients (20%) were diagnosed with VTE of whom 25 (13%) had symptomatic VTE, despite routine thrombosis prophylaxis. The cumulative incidences of VTE at 7, 14 and 21 days were 16% (95% CI, 10-22), 33% (95% CI, 23-43) and 42% (95% CI 30-54) respectively. For symptomatic VTE, these were 10% (95% CI, 5.8-16), 21% (95% CI, 14-30) and 25% (95% CI 16-36). VTE appeared to be associated with death (adjusted HR, 2.4; 95% CI, 1.02-5.5). The cumulative incidence of VTE was higher in the ICU (26% (95% CI, 17-37), 47% (95% CI, 34-58), and 59% (95% CI, 42-72) at 7, 14 and 21 days) than on the wards (any VTE and symptomatic VTE 5.8% (95% CI, 1.4-15), 9.2% (95% CI, 2.6-21), and 9.2% (2.6-21) at 7, 14, and 21 days).
Conclusions:
The observed risk for VTE in COVID-19 is high, particularly in ICU patients, which should lead to a high level of clinical suspicion and low threshold for diagnostic imaging for DVT or PE. Future research should focus on optimal diagnostic and prophylactic strategies to prevent VTE and potentially improve survival.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

